Home/invIOs/Romana Gugenberger
RG

Romana Gugenberger

Managing Director & Chief Medical & Scientific Officer

invIOs

Therapeutic Areas

invIOs Pipeline

DrugIndicationPhase
INV441Glioblastoma MultiformePre-clinical
APN401Advanced Solid TumorsPhase 1
INV451Solid Tumors (CAR enhancer)Pre-clinical
INV461Acute Myeloid Leukemia (AML)Discovery
INV501Undisclosed (Immune activation)Pre-clinical